Nantahala Capital Management’s CRH Medical Corporation CRHM Stock Holding History

Nantahala Capital Management’s Portfolio CRHM Stock Details CRHM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-6,892,005	Closed	-$16.1M	–	144
2020 Q4	$16.1M	Buy	6,892,005 +114,100	+2%	+$280K	0.5%	48
2020 Q3	$14.7M	Hold	6,777,905	–	–	0.45%	49
2020 Q2	$14.2M	Hold	6,777,905	–	–	0.43%	51
2020 Q1	$9.06M	Buy	6,777,905 +243,750	+4%	+$796K	0.34%	50
2019 Q4	$22.6M	Hold	6,534,155	–	–	0.7%	35
2019 Q3	$20.1M	Buy	6,534,155 +250,000	+4%	+$742K	0.74%	36
2019 Q2	$18.9M	Hold	6,284,155	–	–	0.58%	42
2019 Q1	$16.6M	Sell	6,284,155 -250,000	-4%	-$772K	0.52%	41
2018 Q4	$20M	Buy	6,534,155 +378,329	+6%	+$1.25M	0.62%	40
2018 Q3	$24.5M	Buy	6,155,826 +1,236,212	+25%	+$4.56M	0.66%	38
2018 Q2	$15.4M	Buy	4,919,614 +998,421	+25%	+$3.19M	0.62%	42
2018 Q1	$9.91M	Buy	3,921,193 +3,443,505	+721%	+$9.66M	0.45%	46
2017 Q4	$1.26M	Buy	+477,688	New	+$1.07M	0.06%	73

Other funds holding CRHM

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return

BGC

Beutel, Goodman & Co Toronto, Ontario, Canada $14.8B AUM 15.12% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

BCM

Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return

MRCM

Mill Road Capital Management Greenwich, Connecticut $191M AUM 56.95% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Nantahala Capital Management's CRHM Position: Q1 2021 in Review

Nantahala Capital Management sold out of CRH Medical Corporation (CRHM) in Q1 2021, closing a stake of 6,892,005 shares — an estimated $16.1M sold.

Nantahala Capital Management first reported a position in CRHM in Q4 2017 and held it in 13 quarters. The position peaked at $24.5M in Q3 2018. 59 funds tracked by Wall St. Rank hold CRHM as of Q1 2021.

Nantahala Capital Management reported no remaining CRH Medical Corporation position as of Q1 2021 after selling out during the quarter.
Nantahala Capital Management sold 6,892,005 CRH Medical Corporation shares in Q1 2021, an estimated $16.1M.
Nantahala Capital Management first reported a position in CRH Medical Corporation in Q4 2017 and held it in 13 quarters.
Nantahala Capital Management's CRH Medical Corporation position peaked at $24.5M in Q3 2018.
59 funds tracked by Wall St. Rank held CRH Medical Corporation as of Q1 2021.

Based on Nantahala Capital Management's 13F filing for Q1 2021, filed 14 May 2021.